Skip to main content Skip to office menu Skip to footer
Minnesota Legislature

Industry fees could be used to offset some insulin costs

James Holt delivers emotional testimony to the House Commerce Committee on HF485, which would direct the Department of Human Services to implement an insulin assistance program by July 1, 2020. Photo by Paul Battaglia

Insulin producers could be asked to help fund access to the life-saving drug.

“According to some studies, one in four diabetics are rationing their insulin because they cannot afford it,” said Rep. Michael Howard (DFL-Richfield).

He sponsors HF485 that would establish an insulin manufacturer’s registration fee to fund an insulin assistance program. That program would serve people who earn too much money to qualify for existing public programs, but not enough to afford the cost of insulin on their own.

Called the “Alec Smith Emergency Insulin Act,” the bill was approved by House Commerce Committee Tuesday and referred to the House Health and Human Services Policy Committee.

Kristina Moorhead, senior director of state advocacy for the Pharmaceutical Research and Manufacturers of America, testifies against a bill to direct the Department of Human Services to implement an insulin assistance program. Photo by Paul Battaglia

Rationing can have dire consequences, impacting health long-term and even resulting in death, said Nicole Smith-Holt. Her son, Alec, for whom the bill is named, died from diabetic ketoacidosis in 2017.

“Alec was a Type 1 diabetic and you would think for a treatment that has been around for almost a century that we would not be talking about diabetes on someone’s death certificate,” Smith-Holt testified. “… Alec was rationing his insulin because he could not afford the price of his prescriptions.”

He was diagnosed at 24 and dead at 26, a month after losing coverage on his mother’s insurance, his father, James, said. Alec never had the chance to finish learning how to navigate life with the disease.

Concerns over perceived shortcomings of the bill include problems with rebates being absorbed by health insurance and pharmacy benefit managers, according to Kristina Moorhead, senior director of state advocacy for the Pharmaceutical Research and Manufacturers of America. Rebates are the primary way manufacturers help lower drug costs, but insurers and are padding their bottom lines rather than passing the benefits on to patients, she said.

Moorhead also pointed to the high deductibles being offered with many insurances as a hurdle to medication access.

Howard acknowledged that there are many problems to address and called his bill one small piece of the solution.

Sen. Melissa Wiklund (DFL-Bloomington) sponsors the companion, SF472. It awaits action by the Senate Health and Human Services Finance and Policy Committee.


Related Articles


Priority Dailies

House DFL outlines $47.8 billion 2020-21 spending proposal
The plan, dubbed the “Minnesota Values Budget,” would increase spending by $416.9 million over the 2020-21 biennium’s projected base budget.
Budget forecast: Projected surplus drops by almost $500 million, still tops $1 billion
The state has a $1.05 billion projected budget surplus for the upcoming biennium, Minnesota Management and Budget officials announced Thursday.
Walz budget would raise gas tax, emphasize education, health care
Education, health care and community prosperity are key targets for funding in the 2020-21 biennial budget proposed by Gov. Tim Walz.
Committee deadlines for 2019 unveiled
Legislators and the public officially know the timeline for getting bills through the committee process.

Minnesota House on Twitter